Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Proshares Trust (ZBIO) EBT Margin (2023 - 2025)

Historic EBT Margin for Zenas BioPharma (ZBIO) over the last 3 years, with Q1 2025 value amounting to 337.78%.

  • Zenas BioPharma's EBT Margin changed N/A to 337.78% in Q1 2025 from the same period last year, while for Sep 2025 it was 1293.43%, marking a year-over-year change of. This contributed to the annual value of 3218.36% for FY2024, which is 31447100.0% down from last year.
  • As of Q1 2025, Zenas BioPharma's EBT Margin stood at 337.78%.
  • Over the past 5 years, Zenas BioPharma's EBT Margin peaked at 71.25% during Q3 2023, and registered a low of 1130.68% during Q4 2024.
  • Over the past 3 years, Zenas BioPharma's median EBT Margin value was 337.78% (recorded in 2025), while the average stood at 465.74%.